-
Abstract Number: 1694
Pharmacogenetics and Pharmacodynamics of Response to Apremilast in a Phase 3 Clinical Study in Subjects with Active Behçet’s Disease
-
Abstract Number: 1695
Apremilast in Combination vs Monotherapy for Refractory Oral And/or Genital Ulcers in Behçet’s Disease: National Multicenter Study of 51 Cases
-
Abstract Number: 1696
Is the Risk of Tuberculosis Increased in Behçet’s Disease Compared to Other Rheumatological Disorders After Anti-TNF-α Treatment?
-
Abstract Number: 1697
Efficacy of Apremilast for Oral Ulcers Associated with Active Behçet’s Syndrome over 64 Weeks: Long-term Results from the Japanese Subgroup in a Phase III Study
-
Abstract Number: 1698
Development of Machine Learning Models (Artificial Neural Networks) for Prediction of Vision Threatening Behçet’s Disease
-
Abstract Number: 1699
Disease Course of Behçet’s Syndrome Patients Not Fulfilling International Study Group Criteria at Presentation
-
Abstract Number: 1700
Clinical Characteristics and the Level Disease Activity of Behcet´s Disease in China: A Study Based on Smart System of Disease Management (SSDM)
-
Abstract Number: 1701
Amyloidosis in Behcet’s Disease: Experience of a Vasculitis Centre at Silk Road
-
Abstract Number: 1702
Target Organ Associations in Polyarteritis Nodosa (PAN): Results of a Worldwide Collaboration Study
-
Abstract Number: 1703
Increased Levels of IL-2 and IL-4 Promote Th17/Treg Immune Imbalance in Patients with Behcet’s Disease
-
Abstract Number: 1704
Efficacy of Leflunomide for Treatment of Vasculitis
-
Abstract Number: 1705
Cyclophosphamide Therapy for the Neurologic Involvement of Behçet’s Disease – Is It Superior to Azathioprine in Preventing Relapses?
-
Abstract Number: 1706
HLA-B*51 and Its Subtypes in Brazilian Patients with Behçet’s Disease
-
Abstract Number: 1707
IL-6 Promotes IgG4-related Disease by Inducing Fibroblast-dependent Tfh Cell and B Cell Differentiation Factors
-
Abstract Number: 1708
Azathioprine and Glucocorticoid Combination Might Be a Good Treatment Option to Achieve Remission in Patients with IgG4-related Disease
- « Previous Page
- 1
- …
- 114
- 115
- 116
- 117
- 118
- …
- 198
- Next Page »